Treace James T's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed May 2, 2023
- Accession no.
- 0001209191-23-026796
- Filed
- May 2, 2023
- Trade date
- Apr 28-May 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.25M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Treace James TCIK 0001185191 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Common Stock | SSaleDisposed | −40,000 | $25.01 | −$1,000,400 | 871,441 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −7,640 | $25.04 | −$191,305.6 | 863,801 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −2,360 | $25.91 | −$61,147.6 | 861,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.